1Kerner A, Gruberg L, Kapeliovich M, et al. Late stent thrombosis after implantation of a sirolimus-eluting stent [ J ]. Catheter Cardiovasc Interv, 2003, 60: 505-508.
2Ong AT,McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents [ J]. J Am Coil Cardiol, 2005, 45: 2088-2092.
3Pfisterer M, Brunner-La Rocca HP, Buser PT, et ah Late clinical events 'after clopidngrel discontinuation may limit the benefit of drug-eluting stents: an eluting versus bare-metal stents [ J ] 48 : 2584-2591.
4observational study of drug- Cardiol, 2006, Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/ SCAI 2005 guideline update for percutaneous coronary intervention-summary article : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) [ J. J Am Coil Cardiol, 2006, 113 :e166-286.
5Hallas J,Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study[ J]. BMJ, 2006, 333 : 726.
6Gilard M,Amaud B, Le Gal G, et al. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin [ J ]. J Thromb Haemost, 2006, 4: 2508-2509.
7Li XQ, Andersson TB, AhlstriJm M, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome ]?450 activities [ J 1. Drug Metab Dispos, 2004, 32 : 821-827.
8Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary" syndromes[ J]. Eur Heart J, 2007, 28: 1598-1660.
9Hirseh AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease ( lower extremity, renal, mesenteric, and abdominal aortic ): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines ( Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation [ J ]. Circulation, 2006, 113: e463-654.
10Bhatt DL,Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents[ J]. J Am Coll Cardiol, 2008, 52 : 1502-1517.
